Fredrik Landfors

Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk

Fredrik Landfors, Peter Henneman, Elin Chorell et al. · European Heart Journal Open · 2024 · 38 citations · Full text

Medicine, Cardiology, Pharmacology +17

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4

Fredrik Landfors, Elin Chorell, Sander Kersten · Journal of Lipid Research · 2022 · 25 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements

Ismael Valladolid‐Acebes, Karin Åvall, Patricia Recio‐López et al. · Science Advances · 2021 · 15 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +14

A genome-wide association study of imaging-defined atherosclerosis

Anders Gummesson, Per Lundmark, Qiao Sen Chen et al. · Nature Communications · 2025 · 14 citations · Full text

Medicine, Cardiology, Genetics +17

Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma

Oleg Kovrov, Fredrik Landfors, Valeria Saar-Kovrov et al. · Journal of Lipid Research · 2021 · 11 citations · Full text

Life Sciences, Biochemistry, Enzymology +15